Zürcher Nachrichten - Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

EUR -
AED 4.351869
AFN 77.023985
ALL 96.63237
AMD 452.823666
ANG 2.121224
AOA 1086.634242
ARS 1714.678669
AUD 1.704125
AWG 2.135942
AZN 2.016552
BAM 1.955039
BBD 2.405763
BDT 145.96316
BGN 1.990034
BHD 0.448925
BIF 3538.721986
BMD 1.184989
BND 1.512711
BOB 8.253786
BRL 6.228891
BSD 1.194435
BTN 109.687287
BWP 15.628914
BYN 3.402075
BYR 23225.775647
BZD 2.402265
CAD 1.612331
CDF 2683.999101
CHF 0.915765
CLF 0.026002
CLP 1026.709185
CNY 8.237744
CNH 8.246608
COP 4348.606608
CRC 591.469676
CUC 1.184989
CUP 31.402197
CVE 110.222078
CZK 24.343237
DJF 212.697174
DKK 7.467211
DOP 75.200716
DZD 154.410871
EGP 55.902865
ERN 17.774828
ETB 185.552144
FJD 2.612485
FKP 0.865555
GBP 0.865271
GEL 3.193574
GGP 0.865555
GHS 13.084905
GIP 0.865555
GMD 86.504497
GNF 10480.918624
GTQ 9.161432
GYD 249.892689
HKD 9.256278
HNL 31.526723
HRK 7.534037
HTG 156.319128
HUF 380.877851
IDR 19876.405501
ILS 3.662095
IMP 0.865555
INR 108.656932
IQD 1564.790655
IRR 49917.642999
ISK 144.93564
JEP 0.865555
JMD 187.177111
JOD 0.840116
JPY 183.471566
KES 154.209949
KGS 103.627087
KHR 4803.129613
KMF 491.769793
KPW 1066.4897
KRW 1719.182195
KWD 0.363696
KYD 0.995412
KZT 600.736067
LAK 25704.990216
LBP 106962.747619
LKR 369.386157
LRD 215.296161
LSL 18.965415
LTL 3.498963
LVL 0.716788
LYD 7.495081
MAD 10.834781
MDL 20.090177
MGA 5337.921359
MKD 61.616006
MMK 2488.865218
MNT 4226.121106
MOP 9.60526
MRU 47.658441
MUR 53.834423
MVR 18.319442
MWK 2071.193456
MXN 20.620577
MYR 4.671242
MZN 75.555046
NAD 18.965415
NGN 1642.962557
NIO 43.952884
NOK 11.418882
NPR 175.499659
NZD 1.97076
OMR 0.457862
PAB 1.194435
PEN 3.993545
PGK 5.113009
PHP 69.813597
PKR 334.176468
PLN 4.213363
PYG 8000.884374
QAR 4.354904
RON 5.095326
RSD 117.354301
RUB 90.534923
RWF 1742.721367
SAR 4.44571
SBD 9.54107
SCR 17.197303
SDG 712.773565
SEK 10.560067
SGD 1.50588
SHP 0.889048
SLE 28.824866
SLL 24848.616602
SOS 682.634175
SRD 45.089405
STD 24526.870573
STN 24.490463
SVC 10.45093
SYP 13105.469656
SZL 18.959617
THB 37.213986
TJS 11.150158
TMT 4.14746
TND 3.431864
TOP 2.853168
TRY 51.538109
TTD 8.109842
TWD 37.443255
TZS 3075.70229
UAH 51.194065
UGX 4270.337087
USD 1.184989
UYU 46.35195
UZS 14602.313711
VES 409.936611
VND 30738.603075
VUV 140.766514
WST 3.212244
XAF 655.701663
XAG 0.013999
XAU 0.000244
XCD 3.202491
XCG 2.152662
XDR 0.815482
XOF 655.701663
XPF 119.331742
YER 282.412399
ZAR 19.100534
ZMK 10666.318069
ZMW 23.440872
ZWL 381.565831
  • SCS

    0.0200

    16.14

    +0.12%

  • CMSD

    -0.0400

    24.05

    -0.17%

  • RIO

    -4.1000

    91.03

    -4.5%

  • BCE

    0.3700

    25.86

    +1.43%

  • RBGPF

    1.3800

    83.78

    +1.65%

  • BTI

    0.4600

    60.68

    +0.76%

  • CMSC

    0.0500

    23.76

    +0.21%

  • GSK

    0.9400

    51.6

    +1.82%

  • NGG

    0.2000

    85.27

    +0.23%

  • BCC

    0.5100

    80.81

    +0.63%

  • JRI

    0.1400

    13.08

    +1.07%

  • BP

    -0.1600

    37.88

    -0.42%

  • AZN

    0.1800

    92.77

    +0.19%

  • VOD

    -0.0600

    14.65

    -0.41%

  • RYCEF

    -0.4300

    16

    -2.69%

  • RELX

    -0.3700

    35.8

    -1.03%

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

Text size:

ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.

"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."

Solving the $1 million per study problem

While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.

This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.

Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.

The results are compelling:

  • Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.

  • $141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.

  • 51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.

Shaping the Future of Study Operations

Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.

Site Identification & Feasibility

Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.

Study Startup

AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.

Remote Monitoring

AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.

Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.

Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.

All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025

Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/

About Florence Healthcare

Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

Contact Information

Seema Sheth-Voss
[email protected]
(888) 829-0896

SOURCE: Florence Healthcare



View the original press release on ACCESS Newswire

W.Odermatt--NZN